CerroZone Unveils Solution to Destroy Ethylene Oxide Gas
Third-Party Testing Removes Ethylene Oxide Gas Used in Commercial Sterilization Process; Exposure Creates Risk for 14 million Americans
ST. LOUIS, October 29, 2024 – CerroZone™ announced today the results of third-party testing of its CereneAir™ indoor air technology to successful destroy dangerous ethylene oxide (EtO) gas. CereneAir can successfully destroy the cancer-causing industrial gas and clear a room of EtO to undetectable levels in less than two hours, according to independent lab results. CereneAir’s active, always-on technology is safe to operate in occupied rooms allowing the technology to maintain a safe zone for air remediation.
That’s welcome news for 14 million Americans living within five miles of more than 100 U.S. facilities that emit Ethylene oxide (EtO) gas, deemed a carcinogen by the U.S. Environmental Protection Agency (EPA). Inhaling the flammable gas over a lifetime is associated with breast cancer and cancers of the white blood cells and blood cancers. Children are potentially susceptible to the EtO-caused DNA damage.
EtO gas emitters include plants that sterilize medical equipment and spices as well as plants that produce organic chemicals. Communities in close proximity to these facilities and workers in these facilities are at greatest risk.
“As the data shows, our technology can effectively to eliminate EtO gas from a home or workplace through its patented oxidation process, the heart of our air purification technology,” said Marlon Robinson, CerroZone’s Director of Engineering & Operations. “For those seeking to improve their indoor air quality now, whether in an office, facility or home, CereneAir is a proven, available solution.”
Destroying EtO
CereneAir’s patented sanitizing power was validated in a 565-cubic-foot ARE Labs test chamber. In less than two hours, CereneAir Mobile reduced EtO presence by 99.99%, from 10,000 parts per billion to less than 1 ppb, meeting or exceeding all new EPA standards. CereneAir Mobile, FDA-cleared as a medical device, moves up to 310 cubic feet of air per minute (CFM).
The vast majority of air cleaning/purification options available today are based on the concept of trapping airborne pathogens (e.g., HEPA filtration) or otherwise inactivating the pathogens over an extended period of time. CereneAir, however, is specifically designed to kill viruses, bacteria and other pathogens – and to do so immediately. CereneAir also eliminates a range of other viruses, bacteria, volatile organic compounds, and mold.
“Everyone deserves to right to breathe clean, indoor air,” continued Robinson. “With our CereneAir technology, we are working to establish a new standard for indoor air. We want to educate those in areas of exposure about CereneAir and its effectiveness.”
Trusted, Proven Solution
CereneAir provides a more targeted and effective solution for indoor air. The technology’s efficiency is proven. Independent, third-party testing has consistently shown a 99.998 percent elimination rate of a wide range of pathogens in a single pass of just 1.2 seconds.
Coupled with FDA 510(k) Class II medical device clearance and compliance with the American Society of Heating, Refrigeration and Air Conditioning Engineers (ASHRAE) Standard 241, CereneAir is one of the industry’s only platforms to meet these rigorous standards.
About CerroZone
CerroZone LLC is part of Marmon Holdings, Inc., a Berkshire Hathaway company. Marmon Holdings is a global industrial organization comprising 11 diverse business groups and more than 100 autonomous manufacturing and service businesses employing over 30,000 people. For more information, please visit www.CereneAir.com or email sales@cerrozone.com
Contacts:
Steve Marchant, Brodeur Partners for CerroZone, smarchant@brodeur.com